APA

McCloskey E. V., Johansson H., Oden A., Austin M., Siris E., Wang A., Lewiecki E. M., Lorenc R., Libanati C. & Kanis J. A. (20121108). Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX. : Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Chicago

McCloskey Eugene V, Johansson Helena, Oden Anders, Austin Matt, Siris Ethel, Wang Andrea, Lewiecki E Michael, Lorenc Roman, Libanati Cesar and Kanis John A. 20121108. Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX. : Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Harvard

McCloskey E. V., Johansson H., Oden A., Austin M., Siris E., Wang A., Lewiecki E. M., Lorenc R., Libanati C. and Kanis J. A. (20121108). Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX. : Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

MLA

McCloskey Eugene V, Johansson Helena, Oden Anders, Austin Matt, Siris Ethel, Wang Andrea, Lewiecki E Michael, Lorenc Roman, Libanati Cesar and Kanis John A. Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX. : Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 20121108.